These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 37081781)

  • 1. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
    Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
    Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.
    Zhao Y; Dai Q; Fu X; Chen Q; Tang Y; Gao X; Zhou Q
    J Gene Med; 2021 Jun; 23(6):e3325. PubMed ID: 33619796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
    Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
    Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
    Yang B; Zhang B; Qi Q; Wang C
    BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway.
    Zheng HE; Wang G; Song J; Liu Y; Li YM; Du WP
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7750-7759. PubMed ID: 30536319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.